People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

The Colorado Department of Public Health and Environment projected that new HIV diagnoses will total 482 in 2024 — virtually ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

Federal money is used for outreach to people who are vulnerable for HIV and helps cover testing as well as many other ...

Global HIV Study Finds That Cardiovascular ... Targeted Immune Intervention and Stopping ART in Model of SIV Infection Leads to Control of Viral Replication and Reservoirs Sep. 12, 2024 ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...